Lymphoid Neoplasm — Trials

Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

8,885 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,419
Recruiting: 1,268
Ph III recruiting: 131
Growth YoY: +6.7%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,373)

clinicaltrialsPublishedShowing 51–100 of 619 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07674498	Immune Fitness in Older Patients With Relapsed and Refractory Multiple Myeloma(PRIME)	recruiting	N/A	31	Jules Bordet InstituteOTHER	1	Jun 29, 2026	clinicaltrials
NCT07499128	Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event	enrolling by invitation	N/A	136	National Cancer Institute (NCI)NIH	1	Jun 25, 2026	clinicaltrials